GlaxoSmithKline Plc in Consumer Health (World)
Since 2015, GlaxoSmithKline (GSK) has settled in as the global leader in consumer health thanks to its joint venture with Novartis that helped the company to strengthen its OTC portfolio, through key brands such as Voltaren, and expand its presence in Western Europe and China. While regulatory changes and increasing competition are risks to future performance, GSK has taken steps to continue recent success through category expansion, new brand extensions and the Rx-to-OTC switch of Flonase.
Euromonitor International’s GlaxoSmithKline Plc in Consumer Health (World) Company Profile offers detailed strategic analysis of the company’s business, examining its performance in the Consumer Health industry. The report examines company shares by region and sector, product developments, market and distribution strategies, challenges from the competition and future prospects. Use it to understand opportunities and threats facing the business and the factors driving success.
Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook